A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ES / extensive stage

[Related PubMed/MEDLINE]
Total Number of Papers: 42
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ES  (>> Co-occurring Abbreviation)
Long Form:   extensive stage
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 Study. CI, ES SCLC, PFS
2019 Increasing PET Use in Small Cell Lung Cancer: Survival Improvement and Stage Migration in the VA Central Cancer Registry. HR, LCSS, LS, OS, SCLC
2019 Real-World Adherence to Guideline-Recommended Treatment for Small Cell Lung Cancer. LS, SCLC
2019 Role of Focal Adhesion Kinase in Small-Cell Lung Cancer and Its Potential as a Therapeutic Target. FAK, OS, SCLC
2019 Should Stereotactic Radiosurgery Be Considered for Salvage of Intracranial Recurrence after Prophylactic Cranial Irradiation or Whole Brain Radiotherapy in Small Cell Lung Cancer? A Population-Based Analysis and Literature Review. BM, ECOG, IR, LS, MVA, PCI, re-RT, SCLC, WBRT
2018 Characterization of never-smoking and its association with clinical outcomes in Chinese patients with small-cell lung cancer. LS, ORR, OS, PCI, PFS, SCLC
2018 Dose escalation and associated predictors of survival with consolidative thoracic radiotherapy in extensive stage small cell lung cancer (SCLC): A National Cancer Database (NCDB) propensity-matched analysis. NCDB, SCLC, TRT
2018 Is prophylactic cranial irradiation indicated for patients with extensive-stage small cell lung cancer with a complete response to first-line treatment? PCI
2018 Targeting DNA damage repair in small cell lung cancer and the biomarker landscape. DDR, FDA, ICB, PD-L1, SCLC
10  2017 Carboplatin and Etoposide With or Without Palifosfamide in Untreated Extensive-Stage Small-Cell Lung Cancer: A Multicenter, Adaptive, Randomized Phase III Study (MATISSE). MATISSE, SCLC
11  2017 Meta-analysis of the role of bevacizumab in extensive stage small cell lung cancer. CI, HR, ORR, OS, PFS, RCT, SCLC
12  2016 Disease Control Rate at 8 Weeks Predicts Subsequent Survival in Platinum-Treated Extensive Stage Small-Cell Lung Cancer: Results From the Southwest Oncology Group (SWOG) Database. DCR, HR, OS, SCLC, SWOG
13  2016 Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer. CI, mo, OS, SCLC
14  2016 Prophylactic cranial irradiation in small cell lung cancer: A single institution experience. LS, OS, PCI, SCLC
15  2016 Small Cell Lung Cancer. LS, PCI, PET, SCLC
16  2015 Increased serum carcinoembryonic antigen level can predict poor survival of patients with small cell lung cancer. CEA, CHT, HR, OS, SCLC
17  2015 Novel therapies in small cell lung cancer. ADCs, LS, SCLC
18  2015 [Prognostic impact of different chemotherapy strategies on small cell esophageal carcinoma]. EP/CP, LS, MST, OS, SCEC
19  2014 Treatment of small cell lung cancer in academic and community settings: factors associated with receiving standard therapy and survival. LS, SCLC
20  2013 A phase I study of pomalidomide (CC-4047) in combination with cisplatin and etoposide in patients with extensive-stage small-cell lung cancer. AEs, MTD, SCLC
21  2013 Primary small cell carcinoma of the esophagus: patient data metaanalysis and review of the literature. LS, SCCE
22  2013 Prognostic factors and survival of patients with small cell lung cancer in a northeastern Chinese population. LDH, LS, PS, SCLC
23  2013 Treatment of small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. LS, SCLC
24  2012 Phase II study of maintenance sunitinib following irinotecan and carboplatin as first-line treatment for patients with extensive-stage small-cell lung cancer. OS, SCLC
25  2012 Weekly topotecan for recurrent small cell lung cancer - a retrospective Anatolian Medical Oncology Group study. LS
26  2011 Advances in the treatment of small-cell lung cancer. LS, PCI, PET, SCLC
27  2011 Extrapulmonary small cell carcinoma: An indication for prophylactic cranial irradiation? A single center experience. CT, EPSCC, LS, PCI, RT
28  2011 Small cell lung cancer: patterns of care and their influence on survival - 25 years experience of a single Australian oncology unit. LS, SCLC, STA
29  2009 Phase II study of celecoxib with cisplatin plus etoposide in extensive-stage small cell lung cancer. CT, EP, OS, RR, SCLC, TTP
30  2008 Management of small-cell lung cancer: incremental changes but hope for the future. LS, SCLC
31  2008 Phase II trial of weekly dose-dense paclitaxel in extensive-stage small cell lung cancer: cancer and leukemia group B study 39901. SCLC
32  2008 [Clinical analysis of 81 cases with primary small cell carcinoma of the esophagus]. LS, SmCC
33  2007 Could we expect to improve survival in small cell lung cancer? SCLC
34  2005 Pemetrexed (Alimta) in small cell lung cancer. LS, SCLC
35  2005 Seeking new options for the treatment of small-cell lung cancer. LS, NSCLC, SCLC
36  2003 Response to cisplatin-etoposide treatment and survival in patients with small-cell lung cancer in North Lebanon. LS, SCLC
37  1997 Dose-intensive chemotherapy in extensive-stage small-cell lung cancer. CODE, CR, rhG-CSF, SCLC
38  1997 Primary small cell carcinoma of the esophagus: a review of the literature with emphasis on therapy and prognosis. LS, SCC
39  1995 [Recent progress in chemotherapy for advanced lung cancer]. NSCLC, SCLC
40  1993 ["State of the art" of chemotherapy for lung cancer]. NSCLC, RT, SCLC
41  1991 Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy. CR, LS, PR
42  1987 Ifosfamide, etoposide, and thoracic irradiation therapy in 163 patients with unresectable small cell lung cancer. LS, PR